Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8775928 | Urology | 2018 | 30 Pages |
Abstract
A combined model with prostate MRI and the MSKCC nomogram provides no additional risk discrimination over the MSKCC nomogram-based model alone. Evaluation of prostate MRI as a predictive tool should be performed in combination with, not independent of, these clinical risk stratification models.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
John K. Weaver, Eric H. Kim, Joel M. Vetter, Anup Shetty, Robert L. III, Seth A. Strope, Gerald L. Andriole,